Literature DB >> 26450794

Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study.

T Heijnen1, A Wilmer2, D Blockmans3, L Henckaerts3.   

Abstract

OBJECTIVES: Systemic diseases form a rare heterogeneous group of diseases, with important morbidity caused by disease evolution and/or treatment. We describe the clinical features and outcome of patients with these diseases admitted to a referral hospital intensive care unit (ICU).
METHOD: We conducted a retrospective case review of all patients with systemic diseases (n = 86) admitted to the medical ICU of Leuven University Hospital between May 2007 and September 2012.
RESULTS: The most frequent diagnoses were systemic vasculitis (n = 31), sarcoidosis (n = 15), systemic sclerosis (n = 9), and systemic lupus erythematosus (SLE) (n = 7). The main reason for admission was infection (60%), followed by disease-related organ failure (48%). Respiratory failure was the most common organ dysfunction. The mean APACHE II (Acute Physiology and Chronic Health Evaluation II) score was 28 ± 10. Mortality was 19% during ICU admission, 39% during hospital stay, and 58% at the end of follow-up. Death was caused by infection in the majority of cases (56%), and by evolution of the underlying disease in 32%. Only age and APACHE II score were associated with mortality.
CONCLUSIONS: The mortality of patients with systemic diseases admitted to an ICU is high, both during their stay in the ICU and afterwards. Age and APACHE II score, but not infection or immunosuppressive therapy, were associated with mortality.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26450794     DOI: 10.3109/03009742.2015.1067329

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

1.  Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Authors:  Alimohammad Fatemi; Somayeh Shamsaee; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

2.  In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant.

Authors:  Florence Assan; Pierre Bay; Alexis Mathian; Guillaume Hekimian; Nicolas Bréchot; Paul Quentric; Quentin Moyon; Matthieu Schmidt; Fleur Cohen-Aubart; Julien Haroche; Zahir Amoura; Charles-Edouard Luyt; Alain Combes; Marc Pineton de Chambrun
Journal:  Clin Rheumatol       Date:  2022-05-10       Impact factor: 3.650

3.  Short- and long-term prognosis of acute critically ill patients with systemic rheumatic diseases: A retrospective multicentre study.

Authors:  Paul Chabert; William Danjou; Mehdi Mezidi; Julien Berthiller; Audrey Bestion; Abla-Akpene Fred; Claude Guerin; Laurent Argaud; Vincent Piriou; Eric Bonnefoy-Cudraz; Jean-Jacques Lehot; Jean-Luc Fellahi; Thomas Rimmele; Frederic Aubrun; Jean-Christophe Richard; Laure Gallay; Arnaud Hot
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

Review 4.  Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know.

Authors:  Mohanned Mustafa; Easwaradhas Gladston Chelliah; Michael Hughes
Journal:  Rheumatol Int       Date:  2018-03-16       Impact factor: 2.631

5.  Factors Associated with Mortality in Patients with Autoimmune Diseases Admitted to the Intensive Care Unit in Bogota, Colombia.

Authors:  Jorge Armando Carrizosa; Jorge Aponte; Diego Cartagena; Ricard Cervera; Maria Teresa Ospina; Alexander Sanchez
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

6.  Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation.

Authors:  Pierre Bay; Guillaume Lebreton; Alexis Mathian; Pierre Demondion; Cyrielle Desnos; Juliette Chommeloux; Guillaume Hékimian; Nicolas Bréchot; Ania Nieszkowska; Matthieu Schmidt; Fleur Cohen-Aubart; Pascal Leprince; Charles-Edouard Luyt; Zahir Amoura; Alain Combes; Marc Pineton de Chambrun
Journal:  Ann Intensive Care       Date:  2021-02-09       Impact factor: 6.925

7.  Outcome of Patients With Necrotizing Vasculitis Admitted to the Intensive Care Unit (ICU) for Sepsis: Results of a Single-Centre Retrospective Analysis.

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2020-09-02       Impact factor: 3.510

8.  Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study.

Authors:  Saeedeh Shenavandeh; Razieh Naseri
Journal:  Reumatologia       Date:  2017-08-31

9.  Outcome of children with systemic rheumatic diseases admitted to pediatric intensive care unit: An experience of a tertiary hospital.

Authors:  Sulaiman M Al-Mayouf; Rehab Fallatah; Mohammed Al-Twajery; Tareq Alayed; Abdullah Alsonbul
Journal:  Int J Pediatr Adolesc Med       Date:  2019-07-09

10.  Sepsis Mortality Is high in Patients With Connective Tissue Diseases Admitted to the Intensive Care Unit (ICU).

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2021-02-25       Impact factor: 3.510

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.